Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys explains the urgent need for clear regulations surrounding cryptocurrencies and NFTs in India -
Sponsored by Remfry & SagarCA Brijesh and Shubham Shende of Remfry & Sagar describe why the Indian courts seem to be taking a more lenient view of comparative advertising
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains the patent eligibility of AI-related inventions in Japan
-
Sponsored by Satyapon & PartnersSatyapon & PartnersのKritsana MingtongkhumとShantanu Ajit Tambeが、マドリッドプロトコル・ルートでタイに新規商標出願する場合と直接出願する場合を比較し、そのメリットとデメリットについて解説します
-
Sponsored by FirstLaw PC増加するデジタルヘルスケア及びバイオマーカー分野の特許出願に韓国特許庁はどのように対応し審査実務を行っているのだろうか。韓国・第一特許法人の孫世靖(ソンセジョン)弁理士が詳しく解説する。
-
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Shantanu Ajit Tambe of Satyapon & Partners discuss the pros and cons of filing new trademark applications in Thailand via Madrid compared to direct filings
